This study compares the Airtraq and Macintosh laryngoscopes for endotracheal intubation in adult patients, assessing their usability in both standard and challenging airway scenarios. A systematic review of literature and clinical trials was conducted to analyze intubation success rates, time taken for intubation, and incidence of complications using each device. The findings highlight the advantages and limitations of each laryngoscope in different airway conditions, offering insights into optimal device selection based on patient characteristics and clinical settings.

Neo-adjuvant chemotherapy (NAC) is increasingly employed in the treatment of locally advanced gastric cancer (LAGC) to enhance surgical outcomes and improve survival rates. This study aims to evaluate the efficacy of NAC in improving treatment outcomes for patients with LAGC. A retrospective analysis was conducted on a cohort of patients diagnosed with LAGC who received NAC followed by surgical resection. Treatment outcomes were measured in terms of overall survival (OS), disease-free survival (DFS), and pathological response. Our findings indicate a significant improvement in both OS and DFS among patients who received NAC compared to those who underwent surgery alone. Furthermore, a notable proportion of patients achieved a complete pathological response, correlating with improved long-term outcomes. These results underscore the potential of NAC as a vital component of the multidisciplinary treatment approach for LAGC, warranting further investigation in larger, prospective clinical trials.

MetS is a significant public health concern due to its association with severe health outcomes. Early identification and comprehensive management of MetS components are crucial in reducing the global burden of this syndrome. Further research is needed to refine diagnostic criteria, understand the underlying mechanisms, and develop more effective prevention and treatment strategies. The metabolic syndrome (MetS) is a group of illnesses that together better predict a person's risk of cardiovascular disease than any one of the illnesses alone. Human MetS risk is influenced by a combination of environmental and genetic variables. As MetS is a complex disorder with a startlingly high incidence rate these days, developing suitable experimental animal models that closely resemble the illness state in people is essential to resolving the challenges associated with assessing the pathophysiology of MetS in humans. The objective of this study is to provide an overview of the pathophysiology of dietary, genetic, and pharmaceutical models of metabolic syndrome. We will also go over the applicability, advantages, and disadvantages of various animal models. Despite the establishment of many animal models of MetS, more research on.